TNK BIOTECH ApS: Financial statements 2023
CVR: 30691911
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
TNK BIOTECH ApS (CVR 30691911) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -9,250 and a net result of DKK -11,197 compared with DKK -13,146 the year before. Equity in the 2023 report amounted to DKK -48,902. The company had 1 employee in the financial year.
- Gross Profit
- DKK -9,250
- Profit/Loss
- DKK -11,197
- Equity
- DKK -48,902
- Total Assets
- DKK 30,527
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -9 t. | -11 t. | -49 t. | 1 |
| 2022 | - | -10 t. | -13 t. | -38 t. | 1 |
| 2021 | - | -11 t. | -14 t. | -25 t. | 1 |
| 2020 | - | -14 t. | -19 t. | -10 t. | 1 |
| 2019 | - | -13 t. | -18 t. | 8 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
TNK BIOTECH ApS has published its annual report for 2022. Gross profit came to DKK -10,225, and the net result was DKK -13,146.
About TNK BIOTECH ApS
TNK BIOTECH ApS is a Danish company of the type Anpartsselskab based in Kgs. Lyngby, founded in 2007. The company is registered under the industry Investering for egen regning. The company was previously named TNK INVEST ApS. The management consists of Thomas Nitschke Kledal. The company is owned by Thomas Nitschke Kledal. The company has 0 employees (2013). In 2025, the company reported a gross profit of DKK -11,363 and a net result of DKK -17,528 compared with DKK -15,724 the year before. Equity in the 2025 report amounted to DKK -82,154.